These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 18581209)

  • 1. Cyclooxygenase inhibitors down regulate P-glycoprotein in human colorectal Caco-2 cell line.
    Zrieki A; Farinotti R; Buyse M
    Pharm Res; 2008 Sep; 25(9):1991-2001. PubMed ID: 18581209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutive overexpression of P-glycoprotein, rather than breast cancer resistance protein or organic cation transporter 1, contributes to acquisition of imatinib-resistance in K562 cells.
    Hirayama C; Watanabe H; Nakashima R; Nanbu T; Hamada A; Kuniyasu A; Nakayama H; Kawaguchi T; Saito H
    Pharm Res; 2008 Apr; 25(4):827-35. PubMed ID: 17934801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction of celecoxib with MDR transporters enhances the activity of mitomycin C in a bladder cancer cell line.
    Pagliarulo V; Ancona P; Niso M; Colabufo NA; Contino M; Cormio L; Azzariti A; Pagliarulo A
    Mol Cancer; 2013 May; 12():47. PubMed ID: 23705854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential role of cyclooxygenase-2 on the regulation of the drug efflux transporter ABCG2 in breast cancer cell lines.
    Kalalinia F; Elahian F; Behravan J
    J Cancer Res Clin Oncol; 2011 Feb; 137(2):321-30. PubMed ID: 20422426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celecoxib enhanced the sensitivity of cancer cells to anticancer drugs by inhibition of the expression of P-glycoprotein through a COX-2-independent manner.
    Xia W; Zhao T; Lv J; Xu S; Shi J; Wang S; Han X; Sun Y
    J Cell Biochem; 2009 Sep; 108(1):181-94. PubMed ID: 19562670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of two genes in the multidrug resistance of hepatocellular carcinoma: in vivo and clinical studies.
    Sun Z; Zhao Z; Li G; Dong S; Huang Z; Ye L; Liang H; Qu J; Ai X; Zhang W; Chen X
    Tumori; 2010; 96(1):90-6. PubMed ID: 20437864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new intestinal cell culture model to discriminate the relative contribution of P-gp and BCRP on transport of substrates such as imatinib.
    Graber-Maier A; Gutmann H; Drewe J
    Mol Pharm; 2010 Oct; 7(5):1618-28. PubMed ID: 20701289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sinomenine sensitizes multidrug-resistant colon cancer cells (Caco-2) to doxorubicin by downregulation of MDR-1 expression.
    Liu Z; Duan ZJ; Chang JY; Zhang ZF; Chu R; Li YL; Dai KH; Mo GQ; Chang QY
    PLoS One; 2014; 9(6):e98560. PubMed ID: 24901713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
    Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW
    Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The short-chain fatty acid butyrate is a substrate of breast cancer resistance protein.
    Gonçalves P; Gregório I; Martel F
    Am J Physiol Cell Physiol; 2011 Nov; 301(5):C984-94. PubMed ID: 21775706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical interaction of anti-HCV telaprevir with the ABC transporters P-glycoprotein and breast cancer resistance protein.
    Fujita Y; Noguchi K; Suzuki T; Katayama K; Sugimoto Y
    BMC Res Notes; 2013 Nov; 6():445. PubMed ID: 24196382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of P-glycoprotein functionality by vandetanib may reverse cancer cell resistance to doxorubicin.
    Jovelet C; Bénard J; Forestier F; Farinotti R; Bidart JM; Gil S
    Eur J Pharm Sci; 2012 Aug; 46(5):484-91. PubMed ID: 22484209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of 7-
    Chen Y; Li X; Shi L; Ma P; Wang W; Wu N; Gan Y; Han X; Huang S; Kang X; Liu S; Zhen Y
    Aging (Albany NY); 2022 Sep; 14(17):7156-7169. PubMed ID: 36107024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of turmerones on curcumin transportation and P-glycoprotein activities in intestinal Caco-2 cells.
    Yue GG; Cheng SW; Yu H; Xu ZS; Lee JK; Hon PM; Lee MY; Kennelly EJ; Deng G; Yeung SK; Cassileth BR; Fung KP; Leung PC; Lau CB
    J Med Food; 2012 Mar; 15(3):242-52. PubMed ID: 22181075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of efflux transporters involved in distribution and disposition of apixaban.
    Zhang D; He K; Herbst JJ; Kolb J; Shou W; Wang L; Balimane PV; Han YH; Gan J; Frost CE; Humphreys WG
    Drug Metab Dispos; 2013 Apr; 41(4):827-35. PubMed ID: 23382458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-2 inhibitors prevent trinitrobenzene sulfonic acid-induced P-glycoprotein up-regulation in vitro and in vivo.
    Zrieki A; Farinotti R; Buyse M
    Eur J Pharmacol; 2010 Jun; 636(1-3):189-97. PubMed ID: 20361960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver X receptor regulates expression of MRP2 but not that of MDR1 and BCRP in the liver.
    Chisaki I; Kobayashi M; Itagaki S; Hirano T; Iseki K
    Biochim Biophys Acta; 2009 Nov; 1788(11):2396-403. PubMed ID: 19728987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS.
    Daood M; Tsai C; Ahdab-Barmada M; Watchko JF
    Neuropediatrics; 2008 Aug; 39(4):211-8. PubMed ID: 19165709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression.
    Zatelli MC; Luchin A; Tagliati F; Leoni S; Piccin D; Bondanelli M; Rossi R; degli Uberti EC
    Endocr Relat Cancer; 2007 Dec; 14(4):1029-38. PubMed ID: 18045954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer resistance protein and P-glycoprotein in brain cancer: two gatekeepers team up.
    Agarwal S; Hartz AM; Elmquist WF; Bauer B
    Curr Pharm Des; 2011; 17(26):2793-802. PubMed ID: 21827403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.